Cite
HARVARD Citation
Mejia, A. et al. (2022). Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population. Medicine. 101 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mejia, A. et al. (2022). Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population. Medicine. 101 (9), p. . [Online].